2633.HK Stock Analysis
26
Neutral
Based on Eyestock quantitative analysis, 2633.HK`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Market cap $B
0.152
Dividend yield
9.02 %
Shares outstanding
1 921.46 B
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,801 full-time employees The company went IPO on 2016-09-21. The firm operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.